Does Methylene Blue Cure Cancer?

Methylene blue is a deep blue dye. In the last few years it has become a wellness trend. Videos show people dropping it into water and turning their tongues blue. The promises attached to it are broad: more energy, sharper thinking, a longer life. In some posts the claim goes further and says it prevents or cures cancer.

Vials are sold online with vague labels and no medical oversight. The claim we are checking here is the specific one: that taking methylene blue prevents or cures cancer.

Verdict: not proven. There is no approved methylene blue product for treating or preventing any cancer, and no reliable evidence that swallowing it does so.

Methylene blue is a thiazine dye. In the body it works as an oxidation-reduction agent, which means it moves electrons between molecules. That is a real chemical property, and it is exactly why it has one narrow medical job.

It is a prescription drug in the United States. The FDA-approved product is ProvayBlue, a methylene blue injection made by Provepharm SAS under new drug application 204630. FDA approved it on April 8, 2016, with orphan status, meaning it treats a rare condition. It comes in two vial sizes, both at the same strength. It is given into a vein.

Note what that describes. This is a hospital injection with a strength printed on the vial, not a supplement you dose yourself.

The label states the indication in a single sentence. Methylene blue injection is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.

Methemoglobinemia is a blood problem, not a cancer. In it, the iron inside hemoglobin gets chemically altered, so the red cells carry oxygen but cannot hand it over to tissue. Certain drugs and chemicals cause it. Methylene blue reverses the change.

The dosing is precise. The label calls for a weight-based amount given into a vein over 5 to 30 minutes, with a repeat an hour later if the methemoglobin level stays above 30 percent or symptoms persist. Only one dose is used when the kidneys are moderately or severely impaired. This is emergency hospital treatment, worked out and given by clinicians. If two doses do not fix the problem, the label tells prescribers to consider a different treatment. It must not be injected under the skin.

Nothing on that label mentions cancer.

Methylene blue injection carries a boxed warning, the most serious warning FDA uses. Its heading is "SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS AND OPIOIDS."

The warning states that the drug "may cause serious or fatal serotonergic syndrome" when combined with serotonergic drugs and opioids. It names the classes to avoid:

• Selective serotonin reuptake inhibitors (SSRIs), a common antidepressant class.
• Serotonin norepinephrine reuptake inhibitors (SNRIs), another antidepressant class.
• Monoamine oxidase inhibitors (MAOIs).
• Opioids.

Serotonin syndrome is a surge of serotonin activity. It can bring agitation, confusion, a racing heart, high blood pressure, muscle rigidity, tremor, high fever and seizures. It can kill.

This matters more in cancer care than almost anywhere else. Antidepressants are widely prescribed to people with cancer, sometimes for mood and sometimes for hot flashes or nerve pain. Opioids are standard for cancer pain. Someone self-dosing a blue liquid from the internet may be taking two of the four listed classes without connecting them.

The label lists two contraindications, meaning absolute reasons not to use it:

• Severe hypersensitivity to methylene blue.
• Glucose-6-phosphate dehydrogenase deficiency, known as G6PD deficiency, because of the risk of hemolytic anemia.

G6PD deficiency is inherited and common in some populations. Many people who have it do not know. In them, methylene blue can destroy red blood cells. The label's instruction if hemolytic anemia develops is to stop the drug and transfuse.

One more practical warning is easy to miss. Methylene blue interferes with monitoring devices that read light through the skin, such as pulse oximeters. A blue dye in the blood can make an oxygen reading wrong at the moment it is most needed.

Methylene blue does appear in cancer research. It is worth understanding what it is doing there.

Search the federal trials registry for methylene blue in cancer, and the studies that come back are mostly about seeing, not treating. Examples include intradermal methylene blue injection for sentinel lymph node biopsy in breast cancer, sentinel node mapping in endometrial cancer, and staining used during endoscopy to spot colorectal lesions. In these studies the dye marks tissue so a surgeon or endoscopist can find it.

That is a legitimate and useful role. It is also the opposite of a cancer treatment. A dye that shows where a tumor is has not been shown to make a tumor smaller.

FDA maintains a consumer page on this exact pattern. Its title is "Products Claiming to 'Cure' Cancer Are a Cruel Deception."

Two points from it are worth carrying:

• Drugs and devices intended to treat cancer must gain FDA approval or clearance before they are marketed and sold. The review process is what establishes that a product is safe and effective for its stated use.
• Fraudulent cancer products are often advertised as "natural" and falsely labeled as dietary supplements. FDA warns they may cause harm by delaying or interfering with proven treatment, and that without review they may contain dangerous ingredients.

FDA also lists the red flags that mark this kind of marketing: "miracle cure," "works in minutes," "guaranteed." When FDA finds such claims it sends warning letters and can take further legal action.

Products sold as supplements are also not tested for purity or dose the way an approved drug is. A vial bought online may not contain what the label says, and industrial-grade dye is not made to be swallowed.

Tell your oncology team before taking anything, and bring the actual bottle. The interaction list above is the reason. A pharmacist can check it against every drug you are on in a few minutes.

If a product promises a cure, treat the promise itself as the warning sign rather than the ingredient. Our page on whether supplements can cure cancer covers the pattern across products, and our claim checks on baking soda and turmeric show how a real laboratory finding gets stretched into a cure story.

• DailyMed: methylene blue injection label
• Drugs@FDA: ProvayBlue, NDA 204630
• FDA: products claiming to cure cancer
• FDA: questions and answers on dietary supplements
• ClinicalTrials.gov API: methylene blue studies in cancer